Evidence map›Paper›PMID 30569118›Full record

ArticleInternational journal of molecular medicine2019

MicroRNA‑93 inhibits chondrocyte apoptosis and inflammation in osteoarthritis by targeting the TLR4/NF‑κB signaling pathway.

Yanjie Ding, Laifang Wang, Qing Zhao, Zhenzhen Wu, Lingli Kong

Open access · hybridAbstract read
In one paragraph

Article in International journal of molecular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 138 citations in OpenAlex.

  1. Article
  2. Review
  3. 1,25(OH)Clinical rheumatology · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Dexamethasone relieves the inflammatory response caused by inguinal hernia meshes through miR-155.Hernia : the journal of hernias and abdominal wall surgery · 2024
    Article
  9. Article
  10. Exosome miR-4738-3p-mediated regulation ofBiomolecules & biomedicine · 2024
    Article
  11. Article
  12. [miR-515-5p targeting Toll-like receptor 4 regulates myeloid differentiation primary response gene 88/nuclear factor-kappa B pathway to inhibit apoptosis and inflammatory response of osteoarthritis chondrocytes].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Heliyon · 2023
    Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yanjie DingDepartment of Rheumatology and Immunology, Huaihe Hospital of Henan University, Kaifeng, Henan 475000, P.R. China.
Laifang WangDepartment of Rheumatology and Immunology, Huaihe Hospital of Henan University, Kaifeng, Henan 475000, P.R. China.
Qing ZhaoDepartment of Rheumatology and Immunology, Huaihe Hospital of Henan University, Kaifeng, Henan 475000, P.R. China.
Zhenzhen WuDepartment of Rheumatology and Immunology, Huaihe Hospital of Henan University, Kaifeng, Henan 475000, P.R. China.
Lingli KongDepartment of Rheumatology and Immunology, Huaihe Hospital of Henan University, Kaifeng, Henan 475000, P.R. China.
Henan University Huaihe Hospital and Huaihe Clinical Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is a serious disease of the articular cartilage, and inflammation has been implicated in its pathogenesis. Previously, microRNAs (miRNAs) have been proposed as novel regulators of inflammation, however, the functional role of microRNAs in regulating inflammation in OA remains to be fully elucidated. The aim of the present study was to investigate the roles of miRNAs in OA inflammation and the underlying molecular mechanism. Firstly, the miRNA expression patterns were analyzed in the articular cartilage tissues from experimental OA mice using an miRNA microarray. miRNA (miR)‑93 was identified with particular interest due to its reported effects on apoptosis and inflammation suppression. Subsequently, the expression of miR‑93 was further validated in the articular cartilage tissues of OA mice and lipopolysaccharide (LPS)‑stimulated primary chondrocytes. Using this LPS‑induced chondrocyte injury model, the overexpression of miR‑93 enhanced cell viability, improved cell apoptosis and attenuated the inflammatory response, as reflected by reductions in pro‑inflammatory cytokines, including tumor necrosis factor (TNF)‑α, interleukin (IL)‑1β and IL‑6. In addition, Toll‑like receptor 4 (TLR4), an important regulator of the nuclear factor‑κB (NF‑κB) signaling pathway, was identified as a direct target of miR‑93 in chondrocytes. Furthermore, the restoration of TLR4 markedly abrogated the inhibitory effects of miR‑93 on the chondrocyte apoptosis and inflammation induced by LPS. In addition, the overexpression of miR‑93 by agomir‑miR‑93 significantly inhibited the levels of pro‑inflammatory cytokines and cell apoptosis, whereas antagomir‑93 exacerbated apoptosis and inflammation in vivo. Taken together, the results of the study suggested that miR‑93 may be a promising therapeutic target for the treatment of human OA.

Indexed as

MicroRNAsAnimalsApoptosisCartilage, ArticularCells, CulturedChondrocytesInflammationInterleukin-1betaInterleukin-6LipopolysaccharidesMaleMiceMolecular Targeted TherapyNF-kappa BOsteoarthritisSignal TransductionInterleukin-1betaInterleukin-6LipopolysaccharidesMicroRNAsMirn93 microRNA, mouseNF-kappa BTlr4 protein, mouseToll-Like Receptor 4Tumor Necrosis Factor-alpha

Identifiers

PMID30569118
PMCPMC6317687
OpenAlexW2904442971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.